Exchange: NASDAQ·Updated 03:06 PM EST
PTIX logo

PTIX Protagenic Therapeutics Inc

$0.63
$0.02
(3.08%)
Today
Mkt Cap$1.18M
Vol139.00

About PTIX

Protagenic Therapeutics, Inc. operates as a biotechnology company. The firm engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. It offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.
44

Bearish Sentiment

How do you feel about PTIX?

Advertisement|Remove ads.